Stay updated on TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.

Latest updates to the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is an internal versioning change and does not modify study details, eligibility criteria, or results.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated to v3.4.3, and the previous v3.4.2 label was removed.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now shows Revision: v3.4.2 replacing Revision: v3.4.1, with no observable changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1, a minor platform update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedShow glossary was added, and the footer now includes Last Update Submitted that Met QC Criteria and No FEAR Act Data with Revision: v3.4.0. Older wording of Last Update Submitted that met QC Criteria, No FEAR Act data, and the previous Revision: v3.3.4 were removed.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.3.4 is displayed, replacing the previous revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.